随着现代科学技术的飞速发展，临床诊疗技术和方法不断发展和完善。本专栏的开辟旨在创建一个学术交流平台，针对本学科临床工作中的热点和难点，邀请在相关领域做出大量工作并颇有建树的专家和教授，介绍他们的见解和经验，以飨读者。圆桌论坛为个人意见不具共识性。
鼻咽癌手术治疗探讨
Discussion on the surgical treatment of nasopharyngeal carcinoma
-
-
[1] Liu YP, Wen YH, Tang J, et al. Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial[J]. Lancet Oncol, 2021, 22(3): 381-390. doi: 10.1016/S1470-2045(20)30673-2
[2] Kong F, Zhou J, Du C, et al. Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma[J]. BMC Cancer, 2018, 18(1): 1139. doi: 10.1186/s12885-018-5055-5
[3] Tian YM, Guan Y, Xiao WW, et al. Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma[J]. Head Neck, 2016, 38(2): 225-231. doi: 10.1002/hed.23880
[4] Hao CY, Hao SP. The Management of rNPC: Salvage Surgery vs. Re-irradiation[J]. Curr Oncol Rep, 2020, 22(9): 86. doi: 10.1007/s11912-020-00949-0
[5] 中国抗癌协会鼻咽癌专业委员会. 复发鼻咽癌治疗专家共识[J]. 中华放射肿瘤学杂志, 2018, 27(1): 16. doi: 10.3760/cma.j.issn.1004-4221.2018.01.004
[6] Lee AWM, Ng WT, Chan JYW, et al. Management of locally recurrent nasopharyngeal carcinoma[J]. Cancer Treat Rev, 2019, 79: 101890. doi: 10.1016/j.ctrv.2019.101890
[7] Chan JYW, Wong STS, Wei WI. Surgical salvage of recurrent T3 nasopharyngeal carcinoma: Prognostic significance of clivus, maxillary, temporal and sphenoid bone invasion[J]. Oral Oncol, 2019, 91: 85-91. doi: 10.1016/j.oraloncology.2019.02.023
[8] You R, Zou X, Wang SL, et al. New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification system[J]. Eur J Cancer, 2015, 51(13): 1771-1779. doi: 10.1016/j.ejca.2015.05.014
[9] Wei WI, Sham JS. Nasopharyngeal carcinoma[J]. Lancet, 2005, 365(9476): 2041-2054. doi: 10.1016/S0140-6736(05)66698-6
[10] Yoshizaki T, Wakisaka N, Murono S, et al. Endoscopic nasopharyngectomy for patients with recurrent nasopharyngeal carcinoma at the primary site[J]. Laryngoscope, 2005, 115(8): 1517-1519. doi: 10.1097/01.MLG.0000165383.35100.17
[11] Chan JY, Wong ST, Wei WI. Whole-organ histopathological study of recurrent nasopharyngeal carcinoma[J]. Laryngoscope, 2014, 124(2): 446-450. doi: 10.1002/lary.24218
[12] Ong YK, Solares CA, Lee S, et al. Endoscopic nasopharyngectomy and its role in managing locally recurrent nasopharyngeal carcinoma[J]. Otolaryngol Clin North Am, 2011, 44(5): 1141-1154. doi: 10.1016/j.otc.2011.07.002
[13] Liu Q, Sun X, Li H, et al. Types of Transnasal Endoscopic Nasopharyngectomy for Recurrent Nasopharyngeal Carcinoma: Shanghai EENT Hospital Experience[J]. Front Oncol, 2021, 10: 555862. doi: 10.3389/fonc.2020.555862
[14] Liu J, Sun X, Liu Q, et al. Eustachian Tube as a Landmark to the Internal Carotid Artery in Endoscopic Skull Base Surgery. Otolaryngol Head Neck Surg. 2016 Feb; 154(2): 377-382.
[15] Li W, Zhang Q, Chen F, et al. Endoscopic surgery is superior to intensity-modulated radiotherapy in the treatment of advanced recurrent nasopharyngeal carcinoma[J]. Int Forum Allergy Rhinol, 2023, 13(2): 140-150. doi: 10.1002/alr.23051
[16] Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma[J]. Lancet, 2019, 394(10192): 64-80. doi: 10.1016/S0140-6736(19)30956-0
[17] Tian YM, Tian YH, Zeng L, et al. Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy[J]. Br J Cancer, 2014, 110(2): 297-303. doi: 10.1038/bjc.2013.715
[18] Ma BBY, Lim WT, Goh BC, et al. Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium(NCI-9742)[J]. J Clin Oncol, 2018, 36(14): 1412-1418. doi: 10.1200/JCO.2017.77.0388
[19] Fang W, Yang Y, Ma Y, et al. Camrelizumab(SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials[J]. Lancet Oncol, 2018, 19(10): 1338-1350. doi: 10.1016/S1470-2045(18)30495-9
[20] Leong YH, Soon YY, Lee KM, et al. Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: A meta-analysis[J]. Head Neck, 2018, 40(3): 622-631. doi: 10.1002/hed.24993
[21] Chan JY, Tsang RK, Wei WI. Morbidities after maxillary swing nasopharyngectomy for recurrent nasopharyngeal carcinoma[J]. Head Neck. 2015 Apr; 37(4): 487-492.
[22] You R, Zou X, Hua YJ, et al. Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1-T3 nasopharyngeal carcinoma-A case-matched comparison[J]. Radiother Oncol, 2015, 115(3): 399-406. doi: 10.1016/j.radonc.2015.04.024
[23] Zou X, Han F, Ma WJ, et al. Salvage endoscopic nasopharyngectomy and intensity-modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma[J]. Head Neck, 2015, 37(8): 1108-1115. doi: 10.1002/hed.23719
[24] National Comprehensive Cancer Network. Head and neck cancers (version 3.2021). NCCN 2021[EB/OL]. 2021[2021-07-06].
https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf .[25] Wen YH, Wen WP, Chen HX, et al. Endoscopic nasopharyngectomy for salvage in nasopharyngeal carcinoma: a novel anatomic orientation[J]. Laryngoscope, 2010, 120(7): 1298-1302. doi: 10.1002/lary.20958
[26] Wang ZQ, Xie YL, Liu YP, et al. Endoscopic Nasopharyngectomy Combined With Internal Carotid Artery Pretreatment for Recurrent Nasopharyngeal Carcinoma[J]. Otolaryngol Head Neck Surg, 2022, 166(3): 490-497. doi: 10.1177/01945998211011076
[27] Wong EHC, Liew YT, Abu Bakar MZ, et al. A preliminary report on the role of endoscopic endonasal nasopharyngectomy in recurrent rT3 and rT4 nasopharyngeal carcinoma[J]. Eur Arch Otorhinolaryngol, 2017, 274(1): 275-281. doi: 10.1007/s00405-016-4248-2
[28] Liu YP, Li H, You R, et al. Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection[J]. Laryngoscope, 2019, 129(2): 387-395. doi: 10.1002/lary.27317
[29] Liu YP, Wang SL, Zou X, et al. Transcervical endoscopic retropharyngeal lymph node(RPLN)dissection in nasopharyngeal carcinoma with RPLN recurrence[J]. Head Neck, 2021, 43(1): 98-107. doi: 10.1002/hed.26459
[30] Ding X, Lin QG, Zou X, et al. Transoral Robotic Retropharyngeal Lymph Node Dissection in Nasopharyngeal Carcinoma With Retropharyngeal Lymph Node Recurrence[J]. Laryngoscope, 2021, 131(6): E1895-E1902.
[31] Peng Z, Wang Y, Wang Y, et al. Preliminary Efficacy Report and Prognosis Analysis of Endoscopic Endonasal Nasopharyngectomy for Recurrent Nasopharyngeal Carcinoma[J]. Front Surg, 2021, 8: 713926. doi: 10.3389/fsurg.2021.713926
[32] Yang J, Song X, Sun X, et al. Outcomes of recurrent nasopharyngeal carcinoma patients treated with endoscopic nasopharyngectomy: a meta-analysis[J]. Int Forum Allergy Rhinol, 2020, 10(8): 1001-1011. doi: 10.1002/alr.22552
[33] Peng Z, Wang Y, Wang Y, et al. Comparing the Effectiveness of Endoscopic Surgeries With Intensity-Modulated Radiotherapy for Recurrent rT3 and rT4 Nasopharyngeal Carcinoma: A Meta-Analysis[J]. Front Oncol, 2021, 11: 703954. doi: 10.3389/fonc.2021.703954
[34] Chan JY, Wei WI. Recurrent nasopharyngeal carcinoma after salvage nasopharyngectomy[J]. Arch Otolaryngol Head Neck Surg, 2012, 138(6): 572-576. doi: 10.1001/archoto.2012.832
[35] Na'ara S, Amit M, Billan S, et al. Outcome of patients undergoing salvage surgery for recurrent nasopharyngeal carcinoma: a meta-analysis[J]. Ann Surg Oncol, 2014, 21(9): 3056-3062. doi: 10.1245/s10434-014-3683-9
[36] Zhang L, Zhu YX, Wang Y, et al. Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma: a 10-year experience[J]. Ann Surg Oncol, 2011, 18(1): 233-238. doi: 10.1245/s10434-010-1292-9
[37] Liu YP, Xie YL, Zou X, et al. Techniques of endoscopic nasopharyngectomy for localized stage Ⅰ nasopharyngeal carcinoma[J]. Head Neck, 2020, 42(4): 807-812. doi: 10.1002/hed.26090
[38] 陈卓, 邱前辉. 内镜手术治疗鼻咽癌残留或复发的临床疗效及生活质量分析[J]. 中华耳鼻咽喉头颈外科杂志, 2015, 50(11): 896-903. doi: 10.3760/cma.j.issn.1673-0860.2015.11.004
[39] 林少俊, 陈晓钟, 李金高, 等. 复发鼻咽癌治疗专家共识[J]. 中华放射肿瘤学杂志, 2018, 27(1): 16-22. doi: 10.3760/cma.j.issn.1004-4221.2018.01.004
[40] Fu S, Li JS, Dias-Ribeiro E, et al. Aggressive Surgical Resection of Enormous Cervical Metastasis from Nasopharyngeal Carcinoma[J]. Acta Stomatol Croat, 2019, 53(2): 168-173. doi: 10.15644/asc53/2/9
[41] Ngan RK, Yiu HH, Cheng HK, et al. Central nervous system metastasis from nasopharyngeal carcinoma: a report of two patients and a review of the literature[J]. Cancer, 2002, 94(2): 398-405. doi: 10.1002/cncr.10179
[42] Delis S, Biliatis I, Bourli A, et al. Surgical resection of a solitary liver metastasis from nasopharyngeal carcinoma: a case report[J]. Hepatobiliary Pancreat Dis Int, 2006, 5(4): 610-62.
[43] Weitz J, Blumgart LH, Fong Y, et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma[J]. Ann Surg, 2005, 241(2): 269-276. doi: 10.1097/01.sla.0000150244.72285.ad
[44] 项松洁, 黄益灯, 黄加云, 等. 鼻咽癌根治性放疗后颈淋巴结残留的手术治疗[J]. 中国耳鼻咽喉头颈外科, 2006, 13(9): 615-617. doi: 10.16066/j.1672-7002.2006.09.009
[45] 司勇锋, 翁敬锦, 邓卓霞, 等. 鼻咽癌放疗后颈部淋巴结复发rN3的治疗与预后因素分析[J]. 中华耳鼻咽喉头颈外科杂志, 2015, 50(10): 810-813.
[46] Lo WC, Wang CP, Ko JY, et al. Salvage treatment for isolated regional failure of nasopharyngeal carcinoma after primary radiotherapy[J]. Ann Surg Oncol, 2012, 19(3): 1001-1008. doi: 10.1245/s10434-011-2018-3
[47] Sun J, Huang Z, Hu Z, et al. Benefits of local tumor excision and pharyngectomy on the survival of nasopharyngeal carcinoma patients: a retrospective observational study based on SEER database[J]. J Transl Med, 2017, 15(1): 116. doi: 10.1186/s12967-017-1204-x
[48] Zhang Y, Chen L, Hu GQ, et al. Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma[J]. N Engl J Med, 2019, 381(12): 1124-1135. doi: 10.1056/NEJMoa1905287
[49] Sun Y, Li WF, Chen NY, et al. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial[J]. Lancet Oncol, 2016, 17(11): 1509-1520. doi: 10.1016/S1470-2045(16)30410-7
[50] Yang Q, Cao SM, Guo L, et al Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase Ⅲ multicentre randomised controlled trial[J]. Eur J Cancer, 2019, 119: 87-96. doi: 10.1016/j.ejca.2019.07.007
[51] Huang Y, Qiu QH. Endoscopic surgery for early-stage nasopharyngeal carcinoma: a justified initial option[J]. Acta Otolaryngol, 2017, 137(11): 1194-1198. doi: 10.1080/00016489.2017.1351041
[52] Liu YP, Lv X, Zou X, et al. Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage Ⅰ nasopharyngeal carcinoma[J]. Cancer Commun(Lond), 2019, 39(1): 75.
[53] Liu T, Lv J, Qin Y. Standardized tumor volume: an independent prognostic factor in advanced nasopharyngeal carcinoma[J]. Oncotarget, 2017, 8(41): 70299-70309. doi: 10.18632/oncotarget.20313
[54] 邱前辉, 李娜, 张秋航, 等. 内镜手术治疗首诊局部晚期鼻咽癌的疗效分析[J]. 中华耳鼻咽喉头颈外科杂志, 2017, 52(5): 365-371.
[55] 屠规益. 不要轻易对鼻咽癌患者进行手术治疗探索[J]. 临床耳鼻咽喉科杂志, 2002, 16(5): 255-255. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH200205045.htm
[56] Huang L, Chua MLK. Surgery as an alternative to radiotherapy in early-stage nasopharyngeal carcinoma: innovation at the expense of uncertainty[J]. Cancer Commun(Lond), 2020, 40(2-3): 119-121.
[57] Zhang B, Li Y, Weng J, et al. Efficacy and Safety of Endoscopic Nasopharyngectomy Combined With Low-Dose Radiotherapy for Primary T1-2 Nasopharyngeal Carcinoma[J]. Technol Cancer Res Treat, 2021, 20: 15330338211011975.
[58] 赵丽娟, 姜彦, 于龙刚, 等. 鼻咽癌内镜手术治疗临床分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 51-56. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYU201902010.htm
[59] Weng JJ, Wei JZ, Li M, et al. Effects of Surgery Combined with Chemoradiotherapy on Short-and Long-Term Outcomes of Early-Stage Nasopharyngeal Carcinoma[J]. Cancer Manag Res, 2020, 12: 7813-7826. doi: 10.2147/CMAR.S262567
[60] Finegersh A, Said M, Deconde A, et al. Open and endoscopic surgery improve survival for squamous and nonsquamous cell nasopharyngeal carcinomas: An NCDB cohort study[J]. Int Forum Allergy Rhinol, 2022, 12(11): 1350-1361.
-
计量
- 文章访问数: 1347
- PDF下载数: 266
- 施引文献: 0
下载: